Clinical Trial Detail

NCT ID NCT03360721
Title Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Bone Metastatic Prostate Cancer Patients
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors M.D. Anderson Cancer Center
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Apalutamide + Prednisone

Age Groups: adult senior

Additional content available in CKB BOOST